411OInitial results from a phase I/IIa trial evaluating BMS-986158, an inhibitor of the bromodomain and extra-terminal (BET) proteins, in patients (pts) with advanced cancer
Hilton, J, Cristea, M C, Voskoboynik, M, Postel-Vinay, S, Edenfield, W, Gavai, A, Wee, S, Srivastava, N, Klippel, A, Jackson, D, Apfel, A, Chasalow, S D, Williams, D, Donovan, M, Fischer, B, KhaldoyanVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy279.399
Date:
October, 2018
File:
PDF, 81 KB
english, 2018